Skip to main content
Allen Psychiatry Logo

When Antidepressants Haven't Worked: Treatment-Resistant Depression

You are not out of options. Allen Psychiatry offers the full range of next-step treatments — medication re-evaluation, TMS, Spravato®, and intensive programs — on one campus in Allen, TX.

What Is Treatment-Resistant Depression?

Treatment-resistant depression (TRD) generally describes major depressive disorder that has not improved adequately after trying two or more antidepressant medications at an appropriate dose and for an appropriate length of time. It does not mean depression that cannot be treated — it means the first treatments tried were not the right fit, and different, evidence-based options should be considered.

Common experiences when depression hasn't responded to medication

Persistent low mood despite taking antidepressants as prescribed

Loss of interest or pleasure in activities

Fatigue and low energy

Changes in sleep or appetite

Difficulty concentrating

Feelings of hopelessness or worthlessness

Thoughts of self-harm or suicide

If any of these describe you despite trying antidepressants, a re-evaluation with a psychiatric provider is the right next step — not giving up on treatment.

How We Treat Treatment-Resistant Depression, All in One Place

Allen Psychiatry provides every level of care on one campus, so your treatment plan can adapt — up or down — without changing practices.

1

Step 1: A fresh look at your medications

The first step is often a careful re-evaluation rather than a new prescription. Our psychiatric providers review what you have tried, at what doses, and for how long — and whether the diagnosis itself needs a second look. Sometimes an adjusted dose, a switch, or an augmentation strategy makes a meaningful difference before more intensive options are needed.

Learn more about Medication Management
2

TMS: medication-free brain stimulation

Transcranial magnetic stimulation (TMS) is an FDA-cleared, non-invasive option for adults whose depression has not responded adequately to antidepressant medication. Treatment is delivered in brief daily sessions over several weeks using our NeuroStar system, with no anesthesia and no systemic medication side effects. You can drive yourself to and from sessions and continue normal daily activities.

Learn more about TMS Therapy
3

Spravato: FDA-approved specifically for TRD

Spravato (esketamine) nasal spray is FDA-approved for treatment-resistant depression and is taken together with an oral antidepressant. Each dose is administered in our REMS-certified center with post-dose monitoring by our clinical team. Spravato works through a different mechanism than standard antidepressants, which is why it can help when other medications have not.

Learn more about Spravato® (esketamine)
4

When you need more structure: PHP & IOP

If depression is significantly disrupting daily life, our partial hospitalization (PHP) and intensive outpatient (IOP) programs provide structured, multi-day-per-week treatment — group therapy, individual support, and close psychiatric oversight — without an inpatient stay. Many patients use these programs as a bridge: stabilizing first, then stepping down to routine outpatient care with the same practice.

Learn more about PHP & IOP Programs

Related reading: Depression

This page is for general education from a patient's perspective — it is not medical advice, a diagnosis, or a substitute for an evaluation with a qualified provider. Which treatment fits you is a decision made together with your psychiatric provider.

Treatment-Resistant Depression FAQs

Straight answers to the questions patients actually ask

Clinicians generally use the term when depression has not improved adequately after two or more antidepressant medications taken at an appropriate dose for an appropriate duration. If you are unsure whether that describes you, an evaluation with a psychiatric provider can clarify it — bring a list of what you have tried, the doses, and how long you took each one.

No. It means the treatments tried so far were not the right fit. Options such as medication adjustments, TMS, Spravato, and structured intensive programs exist specifically for depression that has not responded to first-line antidepressants.

There is no single right answer — it depends on your treatment history, medical history, preferences, logistics, and insurance coverage. TMS involves brief daily sessions with no medication; Spravato involves twice-weekly monitored sessions initially and is taken with an oral antidepressant. Your psychiatric provider will walk through the trade-offs with you, and because Allen Psychiatry offers both on one campus, the recommendation is based on your situation rather than on which service a clinic happens to sell.

Many major insurance plans cover TMS and Spravato for treatment-resistant depression when clinical criteria are met, and prior authorization is usually required. Our team verifies your specific benefits and handles the authorization paperwork before treatment begins. Call us at 469-340-2777 for a benefits check.

If you are thinking about harming yourself or someone else, do not wait for an appointment. Call or text 988 (Suicide & Crisis Lifeline), call 911, or go to the nearest emergency room.

Still have questions? We're here to help.

If You Are in Immediate Danger

If you or someone you know is in immediate danger of self-harm or suicide:

Depression That Hasn't Responded Still Has Options

Start with a psychiatric evaluation. We'll review what you've tried, verify your insurance benefits, and map the next step together.

Individual results may vary. Treatment is not suitable for everyone and requires a comprehensive evaluation by a qualified provider to determine appropriateness.